MiMedx Announces Statistically Significant Results In New Multicenter Clinical Study Of Healing Of Diabetic Foot Ulcers Using EpiFix®
MARIETTA, Ga., Aug. 24, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ : MDXG ), a leading developer and marketer of regenerative and therapeutic biologics, today…Read More »
Sanuwave Receives FDA De Novo Decision to Immediately Market the Dermapace System for the Treatment of Diabetic Foot Ulcers in the U.S.
SUWANEE, GA, Jan. 02, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) has announced that the U.S. Food and Drug Administration…Read More »
SILVER SPRING, Md., Dec. 28, 2017 /PRNewswire-USNewswire/ — Today, the U.S. Food and Drug Administration permitted the marketing of the…Read More »